These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 2818615
1. Development and inducibility of the hepatic and renal hippurate-synthesizing system in sparse-fur (spf) mutant mice with ornithine transcarbamylase deficiency. Qureshi IA, Lebel S, Letarte J. Biochem Int; 1989 Sep; 19(3):657-66. PubMed ID: 2818615 [Abstract] [Full Text] [Related]
2. Significance of transported glycine in the conjugation of sodium benzoate in spf mutant mice with ornithine transcarbamylase deficiency. Qureshi I, Rouleau T, Letarte J, Ouellet R. Biochem Int; 1986 Jun; 12(6):839-46. PubMed ID: 3091026 [Abstract] [Full Text] [Related]
3. Benzoyl-CoA ligase activity in the liver and kidney cortex of weanling guinea pigs treated with various inducers: relationship with hippurate synthesis and carnitine levels. Ali A, Qureshi IA. Dev Pharmacol Ther; 1992 Jun; 18(1-2):55-64. PubMed ID: 1483363 [Abstract] [Full Text] [Related]
4. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study]. Michalak A, Qureshi IA. Ann Biol Clin (Paris); 1993 Jun; 51(10-11):879-85. PubMed ID: 8210064 [Abstract] [Full Text] [Related]
5. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia. Ratnakumari L, Qureshi IA, Butterworth RF. Biochem Pharmacol; 1993 Jan 07; 45(1):137-46. PubMed ID: 8424807 [Abstract] [Full Text] [Related]
6. The importance of glyoxylate and other glycine precursors in the hepatic and renal conjugation of benzoate in normal and hyperammonemic mice. Qureshi IA, Clermont P, Letarte J. Can J Physiol Pharmacol; 1989 Nov 07; 67(11):1426-30. PubMed ID: 2627683 [Abstract] [Full Text] [Related]
7. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice. Gushiken T, Yoshimura N, Saheki T. Biochem Int; 1985 Nov 07; 11(5):637-43. PubMed ID: 4091843 [Abstract] [Full Text] [Related]
8. Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine. Ratnakumari L, Qureshi IA, Maysinger D, Butterworth RF. J Pharmacol Exp Ther; 1995 Jul 07; 274(1):437-43. PubMed ID: 7616428 [Abstract] [Full Text] [Related]
9. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice]. Qureshi IA, Letarte J, Lebel S, Ouellet R. Diabete Metab; 1986 Oct 07; 12(5):250-5. PubMed ID: 3803679 [Abstract] [Full Text] [Related]
10. Restoration of hepatic cytochrome c oxidase activity and expression with acetyl-L-carnitine treatment in spf mice with an ornithine transcarbamylase deficiency. Mawal YR, Rama Rao KV, Qureshi IA. Biochem Pharmacol; 1998 Jun 01; 55(11):1853-60. PubMed ID: 9714304 [Abstract] [Full Text] [Related]
11. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes. Marini JC, Erez A, Castillo L, Lee B. Am J Physiol Endocrinol Metab; 2007 Dec 01; 293(6):E1764-71. PubMed ID: 17925451 [Abstract] [Full Text] [Related]
12. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse. Batshaw ML, Hyman SL, Coyle JT, Robinson MB, Qureshi IA, Mellits ED, Quaskey S. Pediatr Res; 1988 Apr 01; 23(4):368-74. PubMed ID: 3374991 [Abstract] [Full Text] [Related]
13. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency. Batshaw ML, Yudkoff M, McLaughlin BA, Gorry E, Anegawa NJ, Smith IA, Hyman SL, Robinson MB. Gene Ther; 1995 Dec 01; 2(10):743-9. PubMed ID: 8750014 [Abstract] [Full Text] [Related]
14. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase. Nelson J, Qureshi IA, Vasudevan S, Sarma DS. Chem Biol Interact; 1993 Oct 01; 89(1):35-47. PubMed ID: 8221965 [Abstract] [Full Text] [Related]
15. Activity of the glycine cleavage system in hyperammonemia treated with benzoate. Kodama H, Fujiwara K, Motokawa Y, Tajiri H, Nose O, Kamoshita S. Tohoku J Exp Med; 1983 Jul 01; 140(3):337-8. PubMed ID: 6623463 [Abstract] [Full Text] [Related]
16. [Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate]. Michalak A, Qureshi IA. Can J Physiol Pharmacol; 1993 Jul 01; 71(7):439-46. PubMed ID: 8242478 [Abstract] [Full Text] [Related]
17. [Intrasplenic transplantation of hepatocytes in spf-ash mice with congenital ornithine transcarbamylase deficiency]. Michel JL, Rabier D, Rambaud C, Kamoun P, Brousse N, Vassault A, Pla M, Calise D, Revillon Y. Chirurgie; 1993 Jul 01; 119(10):666-71. PubMed ID: 7729184 [Abstract] [Full Text] [Related]
18. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse. Ye X, Robinson MB, Pabin C, Batshaw ML, Wilson JM. Gene Ther; 2000 Oct 01; 7(20):1761-7. PubMed ID: 11083498 [Abstract] [Full Text] [Related]
19. Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis. Krähenbühl L, Reichen J, Talos C, Krähenbühl S. Hepatology; 1997 Feb 01; 25(2):278-83. PubMed ID: 9021934 [Abstract] [Full Text] [Related]
20. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy. Ratnakumari L, Qureshi IA, Butterworth RF. Metabolism; 1993 Aug 01; 42(8):1039-46. PubMed ID: 8102193 [Abstract] [Full Text] [Related] Page: [Next] [New Search]